Table 5.
Stratification factors in first-line phase III clinical trials in hepatocellular carcinoma
Study arm vs. placebo arm | SUN1170 (sunitinib) | BRISK-FL (brivanib) | LiGHT (linifanib) | SEARCH (+erlotinib) | CheckMate-459 (nivolumab) | REFLECT (lenivatinib) |
---|---|---|---|---|---|---|
Stratification factor | Region Vascular invasion and/or extrahepatic spread Prior TACE |
ECOG-PS score Extrahepatic spread and/or vascular invasion Study site |
Region ECOG-PS score Vascular invasion and/or extrahepatic spread Hepatitis B virus infection |
Region ECOG-PS score Vascular invasion and/or extrahepatic spread Smoking status |
Etiology Region Vascular invasion and/or extrahepatic spread |
Region ECOG-PS score Vascular invasion and/or extrahepatic spread Body weight |